Screening for Osteoporosis in the Adult U.S. Population. ACPM Position Statement on Preventive Practice

American Journal of Preventive Medicine

Volumn 36, Issue 4, 2009, Pages 366-375

  Lim, Lionel S ^a   Hoeksema, Laura J ^a   Sherin, Kevin ^b,c  

^a Griffin Hospital   (United Kingdom)

^b FLORIDA STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSORPTIOMETRY, PHOTON; AGED; CAUSALITY; COMORBIDITY; COST-BENEFIT ANALYSIS; FEMALE; FRACTURES, BONE; GUIDELINES AS TOPIC; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OSTEOPOROSIS; RISK ASSESSMENT; UNITED STATES;

EID: 61649115205     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amepre.2009.01.013     Document Type: Review

References (53)

1. Looker A.C., Orwoll E.S., Johnston Jr. C.C., et al. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res 12 (1997) 1761-1768
2. Riggs B.L., and Melton III L.J. The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone 17 5S (1995) 505S-511S
3. Burge R., Dawson-Hughes B., Solomon D.H., Wong J.B., King A., and Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22 (2007) 465-475
4. Gehlbach S.H., Fournier M., and Bigelow C. Recognition of osteoporosis by primary care physicians. Am J Public Health 92 (2002) 271-273
5. U.S. Preventive Services Task Force. Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med 137 (2002) 526-528
6. Morris C.A., Cabral D., Cheng H., et al. Patterns of bone mineral density testing: current guidelines, testing rates, and interventions. J Gen Intern Med 19 (2004) 783-790
7. Gourlay M.L., Preisser J.S., Linville L.F., and Sloane P.D. Survey of osteoporosis preventive care in community family medicine settings. Fam Med 38 (2006) 724-730
8. Neuner J.M., Binkley N., Sparapani R.A., Laud P.W., and Nattinger A.B. Bone density testing in older women and its association with patient age. J Am Geriatr Soc 54 (2006) 485-489
9. Kern L.M., Powe N.R., Levine M.A., et al. Association between screening for osteoporosis and the incidence of hip fracture. Ann Intern Med 142 (2005) 173-181
10. Cummings S.R., Black D.M., Nevitt M.C., et al. Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. JAMA 263 (1990) 665-668
11. Cummings S.R., Black D.M., Nevitt M.C., et al. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet 341 (1993) 72-75
12. MacLean C., Newberry S., Maglione M., et al. Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med 148 (2008) 197-213
13. Dawson-Hughes B., and Dallal G.E. Effect of radiographic abnormalities on rate of bone loss from the spine. Calcif Tissue Int 46 (1990) 280-281
14. Nayak S., Olkin I., Liu H., et al. Meta-analysis: accuracy of quantitative ultrasound for identifying patients with osteoporosis. Ann Intern Med 144 (2006) 832-841
15. Garnero P., Shih W.J., Gineyts E., Karpf D.B., and Delmas P.D. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 79 (1994) 1693-1700
16. Miller P.D., Baran D.T., Bilezikian J.P., et al. Practical clinical application of biochemical markers of bone turnover: consensus of an expert panel. J Clin Densitom 2 (1999) 323-342
17. Looker A.C., Bauer D.C., Chesnut III C.H., et al. Clinical use of biochemical markers of bone remodeling: current status and future directions. Osteoporos Int 11 (2000) 467-480
18. Nelson H.D., Morris C.D., Kraemer D.F., et al. Osteoporosis in postmenopausal women: diagnosis and monitoring. Evid Rep Technol Assess (Summ) (2001) 1-2
19. Shepherd A.J., Cass A.R., Carlson C.A., and Ray L. Development and internal validation of the male osteoporosis risk estimation score. Ann Fam Med 5 (2007) 540-546
20. Skedros J.G., Sybrowsky C.L., and Stoddard G.J. The osteoporosis self-assessment screening tool: a useful tool for the orthopaedic surgeon. J Bone Joint Surg Am 89 (2007) 765-772
21. Lynn H.S., Woo J., Leung P.C., et al. An evaluation of osteoporosis screening tools for the osteoporotic fractures in men (MrOS) study. Osteoporos Int 19 (2008) 1087-1092
22. Geusens P., Hochberg M.C., van der Voort D.J., et al. Performance of risk indices for identifying low bone density in postmenopausal women. Mayo Clin Proc 77 (2002) 629-637
23. Koh L.K., Sedrine W.B., Torralba T.P., et al. A simple tool to identify Asian women at increased risk of osteoporosis. Osteoporos Int 12 (2001) 699-705
24. Gourlay M.L., Powers J.M., Lui L.Y., and Ensrud K.E. Clinical performance of osteoporosis risk assessment tools in women aged 67 years and older. Osteoporos Int 19 (2008) 1175-1183
25. Adler R.A., Tran M.T., and Petkov V.I. Performance of the Osteoporosis Self-assessment Screening Tool for osteoporosis in American men. Mayo Clin Proc 78 (2003) 723-727
26. Cadarette S.M., Jaglal S.B., Kreiger N., McIsaac W.J., Darlington G.A., and Tu J.V. Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry. CMAJ 162 (2000) 1289-1294
27. Lydick E., Cook K., Turpin J., Melton M., Stine R., and Byrnes C. Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone density. Am J Manag Care 4 (1998) 37-48
28. Sedrine W.B., Chevallier T., Zegels B., et al. Development and assessment of the Osteoporosis Index of Risk (OSIRIS) to facilitate selection of women for bone densitometry. Gynecol Endocrinol 16 (2002) 245-250
29. Siminoski K., Leslie W.D., Frame H., et al. Recommendations for bone mineral density reporting in Canada. Can Assoc Radiol J 56 (2005) 178-188
30. Richy F., Gourlay M., Ross P.D., et al. Validation and comparative evaluation of the osteoporosis self-assessment tool (OST) in a Caucasian population from Belgium. QJM 97 (2004) 39-46
31. Robbins J., Aragaki A.K., Kooperberg C., et al. Factors associated with 5-year risk of hip fracture in postmenopausal women. JAMA 298 (2007) 2389-2398
32. Kanis J.A., Oden A., Johnell O., et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18 (2007) 1033-1046
33. Schousboe J.T., Ensrud K.E., Nyman J.A., Melton III L.J., and Kane R.L. Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women. J Am Geriatr Soc 53 (2005) 1697-1704
34. Tosteson A.N., Melton III L.J., Dawson-Hughes B., et al. Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 19 (2008) 437-447
35. Schousboe J.T., Taylor B.C., Fink H.A., et al. Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. JAMA 298 (2007) 629-637
36. Qaseem A., Snow V., Shekelle P., Hopkins Jr. R., Forciea M.A., and Owens D.K. Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians. Ann Intern Med 149 (2008) 404-415
37. Nelson H.D., Helfand M., Woolf S.H., and Allan J.D. Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137 (2002) 529-541
38. Rimes K.A., and Salkovskis P.M. Prediction of psychological reactions to bone density screening for osteoporosis using a cognitive-behavioral model of health anxiety. Behav Res Ther 40 (2002) 359-381
39. Schuit S.C., van der Klift M., Weel A.E., et al. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone 34 (2004) 195-202
40. Wainwright S.A., Marshall L.M., Ensrud K.E., et al. Hip fracture in women without osteoporosis. J Clin Endocrinol Metab 90 (2005) 2787-2793
41. Anastasilakis A.D., Goulis D.G., Kita M., and Avramidis A. Oral bisphosphonate adverse effects in 849 patients with metabolic bone diseases. Hormones (Athens) 6 (2007) 233-241
42. Wysowski D.K., and Chang J.T. Alendronate and risedronate: reports of severe bone, joint, and muscle pain. Arch Intern Med 165 (2005) 346-347
43. Woo S.B., Hellstein J.W., and Kalmar J.R. Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144 (2006) 753-761
44. Khosla S., Burr D., Cauley J., et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22 (2007) 1479-1491
45. Black D.M., Schwartz A.V., Ensrud K.E., et al. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA 296 (2006) 2927-2938
46. Bone H.G., Hosking D., Devogelaer J.P., et al. Ten years' experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350 (2004) 1189-1199
47. Hodgson S.F., Watts N.B., Bilezikian J.P., et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract 9 (2003) 544-564
48. Neff M.J. ACOG releases guidelines for clinical management of osteoporosis. Am Fam Physician 69 (2004) 1558 60
49. Brown J.P., and Josse R.G. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167S (2002) S1-S34
50. Qaseem A., Snow V., Shekelle P., Hopkins Jr. R., Forciea M.A., and Owens D.K. Screening for osteoporosis in men: a clinical practice guideline from the American College of Physicians. Ann Intern Med 148 (2008) 680-684
51. Liu H., Paige N.M., Goldzweig C.L., et al. Screening for osteoporosis in men: a systematic review for an American College of Physicians Guideline. Ann Intern Med 148 (2008) 685-701
52. Dawson-Hughes B., Tosteson A.N., Melton III L.J., et al. Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int 19 (2008) 449-458
53. Leslie W.D. Absolute fracture risk reporting in clinical practice: a physician-centered survey. Osteoporos Int 19 (2008) 459-463